• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Catalent, Pinduoduo And 3 Stocks To Watch Heading Into Monday

    8/29/22 4:35:55 AM ET
    $CTLT
    $HEI
    $MFGP
    $MNMD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Aerospace
    Industrials
    Get the next $CTLT alert in real time by email

    With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

    • Wall Street expects Catalent, Inc. (NYSE:CTLT) to report quarterly earnings at $1.15 per share on revenue of $1.33 billion before the opening bell. Catalent shares fell 1.7% to $98.00 in after-hours trading.
    • Micro Focus International plc (NYSE:MFGP) shares rose sharply on Friday after the company reached an agreement with OpenText to be acquired for $6 billion. Micro Focus shares jumped 92% to close at $6.01 on Friday.
    • Analysts are expecting Pinduoduo Inc. (NASDAQ:PDD) to have earned $0.39 per share on revenue of $3.49 billion for the latest quarter. The company will release earnings before the markets open. Pinduoduo shares gained 0.2% to $57.70 in the after-hours trading session.

    Check out our premarket coverage here

    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) completed its 1-for-15 reverse share split. MindMed shares fell 1.4% to $0.7803 in the after-hours trading session.
    • Analysts expect HEICO Corporation (NYSE:HEI) to post quarterly earnings at $0.66 per share on revenue of $553.97 million after the closing bell. HEICO shares fell 4.1% to close at $155.89 on Friday.
    Get the next $CTLT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTLT
    $HEI
    $MFGP
    $MNMD

    CompanyDatePrice TargetRatingAnalyst
    Heico Corporation
    $HEI
    2/27/2026Neutral → Outperform
    BNP Paribas Exane
    Heico Corporation
    $HEI
    1/23/2026$385.00Neutral
    Susquehanna
    Heico Corporation
    $HEI
    12/12/2025$367.00Buy
    Citigroup
    PDD Holdings Inc.
    $PDD
    12/9/2025$130.00Buy → Neutral
    Arete
    PDD Holdings Inc.
    $PDD
    11/18/2025Outperform → Mkt Perform
    Bernstein
    Heico Corporation
    $HEI
    11/18/2025$330.00Neutral
    BNP Paribas Exane
    Mind Medicine (MindMed) Inc.
    $MNMD
    10/13/2025$28.00Buy
    Needham
    PDD Holdings Inc.
    $PDD
    8/26/2025$120.00Buy → Neutral
    New Street
    More analyst ratings

    $CTLT
    $HEI
    $MFGP
    $MNMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VPT Expands NewSpace VSC Series with High-Efficiency Point of Load DC-DC Converter

    BLACKSBURG, Va., Feb. 4, 2026 /PRNewswire/ -- VPT, Inc., a HEICO company (NYSE:HEI) (NYSE:HEI), announces the release of the VSCPL1210SG, the first point of load DC–DC converter in its award–winning VSC Series of space–grade COTS power supplies. Delivering up to 10 A of output current with peak efficiency up to 95%, the VSCPL1210SG expands VPT's NewSpace product offering and completes a full power–conversion solution that includes isolated DC–DC converters, point of load converters, and EMI filters. The VSC Series is a commercial off–the–shelf (COTS) product line designed for

    2/4/26 9:37:00 AM ET
    $HEI
    Aerospace
    Industrials

    MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

    Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that Rob Barrow, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT. "It is a privilege to participate in the J.P. Morgan Healthcare Conference as we continue to share the progress MindMed is making to forge a new era of psychiatry," said Rob Barrow, Chief Executive Officer. "The conference provides a meaningful opportunity to engage with the investment community as we prepare for a de

    12/18/25 7:01:00 AM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    One Equity Partners' Portfolio Company EthosEnergy to Sell Aerospace & Defense Business

    One Equity Partners ("OEP"), a middle market private equity firm, today announced that portfolio company EthosEnergy ("Ethos") has agreed to sell its aerospace and defense business comprised of EthosEnergy Accessories and Components Limited and EthosEnergy Accessories and Components, LLC (collectively referred to as "Ethos A&C" or "Ethos' A&D Business"), to Wencor Group LLC, a subsidiary of HEICO Corporation (NYSE:HEI). Financial terms of the private transaction were not disclosed. "This transaction is part of Ethos' broader transformation to simplify and optimize the company's structure to deliver long-term value for customers," said Ante Kusurin, Partner at One Equity Partners. "Shortly

    12/16/25 3:49:00 PM ET
    $HEI
    Aerospace
    Industrials

    $CTLT
    $HEI
    $MFGP
    $MNMD
    SEC Filings

    View All

    Mind Medicine (MindMed) Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - Mind Medicine (MindMed) Inc. (0001813814) (Filer)

    1/12/26 8:24:42 AM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 144 filed by Mind Medicine (MindMed) Inc.

    144 - Mind Medicine (MindMed) Inc. (0001813814) (Subject)

    12/29/25 4:15:20 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by PDD Holdings Inc.

    6-K - PDD Holdings Inc. (0001737806) (Filer)

    12/19/25 7:40:06 AM ET
    $PDD
    EDP Services
    Technology

    $CTLT
    $HEI
    $MFGP
    $MNMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gryska David W bought $17,925 worth of shares (2,500 units at $7.17), increasing direct ownership by 14% to 19,851 units (SEC Form 4)

    4 - Mind Medicine (MindMed) Inc. (0001813814) (Issuer)

    12/5/24 4:30:05 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Gryska David W bought $20,930 worth of shares (3,500 units at $5.98), increasing direct ownership by 25% to 17,351 units (SEC Form 4)

    4 - Mind Medicine (MindMed) Inc. (0001813814) (Issuer)

    8/26/24 7:00:03 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Executive Officer Barrow Robert bought $6,215 worth of shares (1,000 units at $6.21), increasing direct ownership by 0.18% to 565,543 units (SEC Form 4)

    4 - Mind Medicine (MindMed) Inc. (0001813814) (Issuer)

    8/20/24 9:14:04 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    $CTLT
    $HEI
    $MFGP
    $MNMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HEICO upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded HEICO from Neutral to Outperform

    2/27/26 8:21:04 AM ET
    $HEI
    Aerospace
    Industrials

    Susquehanna initiated coverage on HEICO with a new price target

    Susquehanna initiated coverage of HEICO with a rating of Neutral and set a new price target of $385.00

    1/23/26 8:19:26 AM ET
    $HEI
    Aerospace
    Industrials

    Citigroup initiated coverage on HEICO with a new price target

    Citigroup initiated coverage of HEICO with a rating of Buy and set a new price target of $367.00

    12/12/25 8:50:45 AM ET
    $HEI
    Aerospace
    Industrials

    $CTLT
    $HEI
    $MFGP
    $MNMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Sullivan Mark sold $148,244 worth of shares (11,276 units at $13.15), decreasing direct ownership by 4% to 282,576 units (SEC Form 4)

    4 - Mind Medicine (MindMed) Inc. (0001813814) (Issuer)

    12/29/25 5:00:03 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Executive Officer Barrow Robert sold $339,072 worth of shares (25,791 units at $13.15), decreasing direct ownership by 3% to 778,477 units (SEC Form 4)

    4 - Mind Medicine (MindMed) Inc. (0001813814) (Issuer)

    12/29/25 5:00:06 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Medical Officer Karlin Daniel sold $73,623 worth of shares (5,600 units at $13.15), decreasing direct ownership by 1% to 425,025 units (SEC Form 4)

    4 - Mind Medicine (MindMed) Inc. (0001813814) (Issuer)

    12/29/25 5:00:08 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    $CTLT
    $HEI
    $MFGP
    $MNMD
    Leadership Updates

    Live Leadership Updates

    View All

    VPT Announces New VP of North American Sales, Trevor Rice

    BLACKSBURG, Va., June 10, 2025 /PRNewswire/ -- VPT, Inc., a global leader in high-reliability power conversion solutions and a HEICO company (NYSE:HEI) (NYSE:HEI), is pleased to announce the appointment of Trevor Rice as Vice President of North American Sales. "Trevor's extensive technical background and decades of leadership in power conversion solutions make him an exceptional addition to our team," —Paul AndersenWith more than 25 years of sales management experience, Rice will lead VPT's Outside Sales Team, Inside Sales Operations, and an extensive network of North American

    6/10/25 10:42:00 AM ET
    $HEI
    Aerospace
    Industrials

    MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer

    Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Brandi L. Roberts as its Chief Financial Officer (CFO), effective June 2, 2025. In her new role, Ms. Roberts will join MindMed's executive leadership team where she will oversee all aspects of financial strategy, capital planning, accounting, investor relations and information technology as the Company advances its clinical development and commercial priorities for its lead product candidate MM120 orally disintegrating tablet (ODT) for generalized anxiety disorder (GAD

    5/27/25 7:00:00 AM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    MindMed Appoints Matt Wiley as Chief Commercial Officer

    Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Matt Wiley as its Chief Commercial Officer (CCO). In his new role, Mr. Wiley will serve as a member of the executive team, overseeing the Company's commercial vision and strategy as it prepares for the potential launch of its first product, MM120 orally disintegrating tablet (ODT) for generalized anxiety disorder (GAD) and major depressive disorder (MDD). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250317

    3/17/25 7:00:00 AM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    $CTLT
    $HEI
    $MFGP
    $MNMD
    Financials

    Live finance-specific insights

    View All

    PDD Holdings Announces Third Quarter 2025 Unaudited Financial Results

    DUBLIN and SHANGHAI, Nov. 18, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD), today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Total revenues in the quarter were RMB108,276.5 million (US$115,209.5 million), an increase of 9% from RMB99,354.4 million in the same quarter of 2024.Operating profit in the quarter was RMB25,025.9 million (US$3,515.4 million), compared with RMB24,292.5 million in the same quarter of 2024. Non-GAAP2 operating profit in the quarter was RMB27,079.4 million (US$3,803.8 million), compared with RMB26,770.5 million in the same quarter of 2024.Net

    11/18/25 5:30:00 AM ET
    $PDD
    EDP Services
    Technology

    PDD Holdings to Report Third Quarter 2025 Unaudited Financial Results on November 18, 2025

    DUBLIN and SHANGHAI, Nov. 11, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD) today announced that it will report its unaudited financial results for the third quarter ended September 30, 2025, before U.S. markets open on Tuesday, November 18, 2025. The Company's management will hold an earnings conference call at 7:30 AM ET on November 18, 2025 (12:30 PM GMT and 8:30 PM HKT on the same day). The conference call will be webcast live at https://investor.pddholdings.com/investor-events. The webcast will be available for replay at the same website following the conclusion of the call. About PDD Holdings: PDD Holdings is a multinational commerce gro

    11/11/25 10:00:00 AM ET
    $PDD
    EDP Services
    Technology

    PDD Holdings Announces Second Quarter 2025 Unaudited Financial Results

    DUBLIN and SHANGHAI, Aug. 25, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD), today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Total revenues in the quarter were RMB103,984.8 million (US$114,515.7 million), an increase of 7% from RMB97,059.5 million in the same quarter of 2024.Operating profit in the quarter was RMB25,792.9 million (US$3,600.6 million), a decrease of 21% from RMB32,564.5 million in the same quarter of 2024. Non-GAAP2 operating profit in the quarter was RMB27,747.8 million (US$3,873.4 million), a decrease of 21% from RMB34,987.3 million in the same quarter

    8/25/25 6:30:33 AM ET
    $PDD
    EDP Services
    Technology

    $CTLT
    $HEI
    $MFGP
    $MNMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Catalent Inc.

    SC 13G/A - Catalent, Inc. (0001596783) (Subject)

    11/14/24 4:35:03 PM ET
    $CTLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Mind Medicine (MindMed) Inc.

    SC 13G/A - Mind Medicine (MindMed) Inc. (0001813814) (Subject)

    11/14/24 4:05:16 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Catalent Inc.

    SC 13G/A - Catalent, Inc. (0001596783) (Subject)

    11/14/24 9:50:26 AM ET
    $CTLT
    Biotechnology: Pharmaceutical Preparations
    Health Care